Cargando…
It’s Not Always SIAD: Immunotherapy-Triggered Endocrinopathies Enter the Field of Cancer-Related Hyponatremia
While the syndrome of inadequate antidiuresis (SIAD) is still the most common cause of hyponatremia in cancer patients, the rise in endocrine immune-related adverse events (irAEs) owing to immune checkpoint inhibitors (ICI) considerably shaped the differential diagnosis of electrolyte disorders in c...
Autores principales: | Bischoff, Jenny, Fries, Charlotte, Heer, Alexander, Hoffmann, Friederike, Meyer, Carsten, Landsberg, Jennifer, Fenske, Wiebke K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8962447/ https://www.ncbi.nlm.nih.gov/pubmed/35356006 http://dx.doi.org/10.1210/jendso/bvac036 |
Ejemplares similares
-
Chronic Hyponatremia Due to the Syndrome of Inappropriate Antidiuresis (SIAD) in an Adult Woman with Corpus Callosum Agenesis (CCA)
por: Silveira, Marcelo Augusto Duarte, et al.
Publicado: (2018) -
What Does SGLT2 Inhibition Add in Managing Hyponatremia Secondary to Syndrome of Inappropriate Antidiuresis (SIAD)?
por: Jalal, Fadzliana Hanum, et al.
Publicado: (2021) -
Therapy for SIAD: what does the future hold?
por: Tzoulis, Ploutarchos
Publicado: (2023) -
Tolvaptan for the treatment of the syndrome of inappropriate
antidiuresis (SIAD)
por: Tzoulis, Ploutarchos, et al.
Publicado: (2023) -
Hyponatraemia and the syndrome of inappropriate antidiuresis (SIAD) in cancer
por: Donald, D Mc, et al.
Publicado: (2022)